Completed PHASE4 INTERVENTIONAL NCT00000442

Naltrexone for Relapse Prevention

Etiology and Treatment of Alcohol Dependence

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Updated 5 times since 2017 Last updated: Jun 17, 2011 Completion: Dec 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Alcoholism, this trial is completed. The trial is conducted by National Institute on Alcohol Abuse and Alcoholism (NIAAA) and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
UConn Health

Data source: UConn Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States